Dan Janney has been investing in life sciences companies for more than 20 years. Mr. Janney joined Alta Partners at its founding and is a Managing Director. His focus on working with talented entrepreneurs to create companies around novel insights in biology and new approaches to drug discovery has led to the funding and development of 32 companies. Prior to Alta, he was a senior investment banker at Montgomery Securities where he advised life science companies on over $8 billion of equity and merger transactions. Mr. Janney is currently on the board of directors of several public and private companies, including Esperion Therapeutics, Evolve Biosystems, Prolacta Bioscience, Sutro Biopharma, and Viveve. In addition, he led Alta’s investments in Astex Pharmaceuticals (acquired by Supergen), Cellective (acquired by Medimmune), ChemGenex (acquired by Cephalon), CoTherix (acquired by Actelion), DeUnity Health (acquired by United Health), Dynavax, Endonetics (acquired by Medtronic), Ilex Oncology (acquired by Millennium Pharmaceuticals), InterMune (acquired by Roche), LJL Biosystems (acquired by Molecular Devices), Mako Surgical (acquired by Stryker) and Triangle Pharmaceuticals (acquired by Gilead).
In 2006 and 2007, Mr. Janney was listed in Forbes’ Midas 100 List of Top Tech Investors. He is a member of The President’s Council of the J. David Gladstone Institutes and serves on the Board of Regents of Georgetown University. He holds a Bachelor of Arts from Georgetown University and an MBA from the Anderson School at the University of California, Los Angeles.
What is Daniel Janney's net worth?
The estimated net worth of Daniel Janney is at least $132,611.85 as of June 8th, 2023. Mr. Janney owns 126,297 shares of Allakos stock worth more than $132,612 as of April 23rd. This net worth estimate does not reflect any other investments that Mr. Janney may own. Learn More about Daniel Janney's net worth.
How do I contact Daniel Janney?
Has Daniel Janney been buying or selling shares of Allakos?
Daniel Janney has not been actively trading shares of Allakos during the past quarter. Most recently, Daniel Janney sold 17,308 shares of the business's stock in a transaction on Friday, March 26th. The shares were sold at an average price of $115.17, for a transaction totalling $1,993,362.36. Learn More on Daniel Janney's trading history.
Who are Allakos' active insiders?